MUC1 and neoplasm: Although cumulative doses of 4 and 10 Gy were found to be sublethal (Figure 1), they were still able to enhance T cell-mediated lysis of each tumor cell line by CTLs specific for MUC-1, brachyury, and CEA tumor antigens (Figure 2).